These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 15706582)
1. Diagnosis and treatment of children with aplastic anemia. Kurre P; Johnson FL; Deeg HJ Pediatr Blood Cancer; 2005 Nov; 45(6):770-80. PubMed ID: 15706582 [TBL] [Abstract][Full Text] [Related]
2. An update on the management of severe idiopathic aplastic anaemia in children. Davies JK; Guinan EC Br J Haematol; 2007 Feb; 136(4):549-64. PubMed ID: 17214739 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients. George B; Mathews V; Viswabandya A; Lakshmi KM; Srivastava A; Chandy M Pediatr Hematol Oncol; 2010 Mar; 27(2):122-31. PubMed ID: 20201693 [TBL] [Abstract][Full Text] [Related]
5. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation. Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children. Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946 [TBL] [Abstract][Full Text] [Related]
7. Aplastic anemia: therapeutic updates in immunosuppression and transplantation. Scheinberg P Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant]. Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653 [TBL] [Abstract][Full Text] [Related]
9. High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children. Audino AN; Blatt J; Carcamo B; Castaneda V; Dinndorf P; Wang WC; Whitlock JA; Hord JD Pediatr Blood Cancer; 2010 Feb; 54(2):269-72. PubMed ID: 19827142 [TBL] [Abstract][Full Text] [Related]
10. Outcome of children with aplastic anemia treated with immunosuppressive therapy. Pongtanakul B; Das PK; Charpentier K; Dror Y Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO). Jeong DC; Chung NG; Kang HJ; Koo HH; Kook H; Kim SK; Kim SY; Kim HS; Kim HM; Park KD; Park SK; Park JS; Park JE; Park HJ; Park YS; Seo JJ; Sung KW; Shin HY; Ahn HS; Ryu KH; Ryu KH; Yoo ES; Lyu CJ; Lee KS; Lee KC; Lee SY; Lee YH; Lim YT; Lim YJ; Jung HL; Cho B; Choi YM; Hah JO; Hwang TJ; Kim HK J Pediatr Hematol Oncol; 2011 Apr; 33(3):172-8. PubMed ID: 21325968 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP). Barone A; Lucarelli A; Onofrillo D; Verzegnassi F; Bonanomi S; Cesaro S; Fioredda F; Iori AP; Ladogana S; Locasciulli A; Longoni D; Lanciotti M; Macaluso A; Mandaglio R; Marra N; Martire B; Maruzzi M; Menna G; Notarangelo LD; Palazzi G; Pillon M; Ramenghi U; Russo G; Svahn J; Timeus F; Tucci F; Cugno C; Zecca M; Farruggia P; Dufour C; Saracco P; Blood Cells Mol Dis; 2015 Jun; 55(1):40-7. PubMed ID: 25976466 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor. Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223 [TBL] [Abstract][Full Text] [Related]
15. Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation. Cesaro S; Marsh J; Tridello G; Rovò A; Maury S; Montante B; Masszi T; Van Lint MT; Afanasyev B; Iriondo Atienza A; Bierings M; Carbone C; Doubek M; Lanino E; Sarhan M; Risitano A; Steinerova K; Wahlin A; Pegoraro A; Passweg J Acta Haematol; 2010; 124(1):19-22. PubMed ID: 20606411 [TBL] [Abstract][Full Text] [Related]
17. Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia. Führer M Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S97-100. PubMed ID: 18978755 [TBL] [Abstract][Full Text] [Related]
18. How I manage aplastic anaemia in children. Samarasinghe S; Webb DK Br J Haematol; 2012 Apr; 157(1):26-40. PubMed ID: 22348483 [TBL] [Abstract][Full Text] [Related]
19. Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia. Walsh TJ Semin Hematol; 2009 Jul; 46(3):191-7. PubMed ID: 19549573 [TBL] [Abstract][Full Text] [Related]
20. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia]. Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]